Abstract
The aim of this study was to determine the prevalence of upper gastrointestinal symptoms (UGIS) in a general population and quantify the relationship of those symptoms to health-care utilization and quality of life. In-person interviews were conducted with 2056 United States and Canadian residents selected at random. Subjects reported frequency and severity for 11 symptoms, prescription and over-the-counter medication use, primary care and specialty physician visits in prior three months, and completed the Psychological General Well-Being Scale. For analyses, subjects were classified into four mutually exclusive symptom groups: gastroesophageal reflux disease (GERD) -like, GERD plus motility-like (GERD+), ulcerlike, and motility-like. Of the total sample, 51.4% reported the occurrence of at least one UGIS in the prior three months. Subjects in the GERD+ and ulcer groups used more prescription medications and were more likely to see a physician about the symptoms (P < 0.001). Subjects with symptoms demonstrated poorer quality of life compared to subjects with no symptoms. The prevalence of UGIS in the general population is high and symptoms are associated with significant health-care utilization and poorer quality of life.
Similar content being viewed by others
REFERENCES
Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ: Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 136:165–177, 1992
Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, Richter JE, Koch GG: US householder survey of functional gastrointestinal disorders: Prevalence, sociodemography, and health impact. Dig Dis Sci 38:1569–1580, 1993
Sonnenberg A, Everhart JE: Socio-economic determinants of digestive disease. Gastroenterol Int 6:100–114, 1993
Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ: Dyspepsia and dyspepsia subgroups: A population-based study. Gastroenterology 102:1259–1268, 1992
Revicki DA, Wood M, Wiklund I, Crawley J: Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Qual Life Res 7:75–83, 1998
Revicki DA, Wood M, Maton PN, Sorensen S: The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 104:252–258, 1998
Dupuy H: The Psychological General Well-Being (PGWB) index. In Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. NK Wenger, ME Mattson, CD Furberg, J Elinson (eds). Greenwich, Connecticut, Le Jacq Publishing, 1984, pp 170–183, 353–356
Colin-Jones DG: The management of dyspepsia. Scand J Gastroenterol Suppl 155:96–100, 1988
Talley NJ, Colin-Jones DG, Koch KL, Koch M, Nyren O, Stanghellini V: Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterol Int 4:145–160, 1991
Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR: Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 105:1378–1386, 1993
Talley NJ: The role of Helicobacter pylori in non-ulcer dyspepsia: A debate-against. Gastroenterol Clin North Am 22:153–167, 1993
Kay L, Jorgensen T: Redefining abdominal syndromes. Results of a population-based study. Scand J Gastroenterol 31:469–475, 1996
Nebel OT, Fornes MF, Castell DO: Symptomatic gastroesophageal reflux: Incidence and precipitating factors. Dig Dis Sci 21:953–956, 1976
Locke GR 3rd, Talley NJ, Fett SR, Zinsmeister AR, Melton LJ 3rd. Prevalance and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota. Gastroenterology 112:1448–1456, 1997
Kay L, Jorgensen T: Epidemiology of upper dyspepsia in a random population. Prevalence, incidence, natural history, and risk factors. Scand J Gastroenterol 29:1–6, 1994
Agreus L, Svardsudd K, Nyren O, Tibblin G: Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time. Gastroenterology 109:671–680, 1995
Kuykendall DH, Rabeneck L, Campbell CJM, Wray NP: Dyspepsia: how should we measure it? J Clin Epidemiol 51(2):99–106, 1998
American Gastroenterological Association Technical Review: Evaluation of dyspepsia. Gastroenterology 114:582–595, 1998
American Gastroenterological Association Medical Position Statement: Evaluation of dyspepsia. Gastroenterology 114:579–581, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frank, L., Kleinman, L., Ganoczy, D. et al. Upper Gastrointestinal Symptoms in North America. Dig Dis Sci 45, 809–818 (2000). https://doi.org/10.1023/A:1005468332122
Issue Date:
DOI: https://doi.org/10.1023/A:1005468332122